...
机译:雅各的晚期毒性和临床结果,雅各的5年12 / 0405-卓越02试验比较两种Neoadjuvant ChemorAdiotapy治疗方案进行中间风险直肠癌
Montpellier Canc Inst Dept Radiat Oncol Montpellier France;
Antoine Lacassagne Ctr Dept Radiat Oncol 33 Ave Valombrose F-06189 Nice France;
Montpellier Canc Inst Biometr Unit Montpellier France;
Leon Berard Ctr Dept Radiat Oncol Lyon France;
St Louis Hosp Dept Radiat Oncol Paris France;
Armorican Ctr Radiotherapy &
Radiol Dept Radiat Oncol Plerin France;
CHU Bordeaux Dept Radiat Oncol Teaching Hosp Bordeaux France;
Univ Cote Azur Nice France;
Oncol Inst Loire Dept Med Oncol St Priest En Jarez France;
CHU Reims Teaching Hosp Dept Med Oncol Reims France;
Oscar Lambret Ctr Dept Radiat Oncol Lille France;
CHU Louis Pasteur Teaching Hosp Dept Med Oncol Colmar France;
St Catherine Inst Dept Radiat Oncol Avignon France;
St Marguerite Private Hosp Toulon France;
West Oncol Inst Dept Radiat Oncol St Herblain France;
Inst Bergonie Dept Med Oncol Bordeaux France;
Jean Bernard Ctr Dept Med Oncol Le Mans France;
Jean Mermoz Private Hosp Dept Med Oncol Lyon France;
CHU Timone Dept Med Oncol Teaching Hosp Marseille France;
CHU Dijon Teaching Hosp Dept Med Oncol Dijon France;
Montpellier Canc Inst Biometr Unit Montpellier France;
Unicancer Paris France;
Oncol Inst Lorraine Dept Med Oncol Vandoeuvre Les Nancy France;
Antoine Lacassagne Ctr Dept Radiat Oncol 33 Ave Valombrose F-06189 Nice France;
rectal cancer; intermediate risk; oxaliplatin; neoadjuvant; chemoradiotherapy;
机译:雅各的晚期毒性和临床结果,雅各的5年12 / 0405-卓越02试验比较两种Neoadjuvant ChemorAdiotapy治疗方案进行中间风险直肠癌
机译:两种针对局部晚期直肠癌的新辅助放化疗方案的比较:III期试验ACCORD 12 / 0405-Prodige 2的结果。
机译:直肠癌新辅助放化疗和保守治疗后的临床完全缓解(cCR)。 ACCORD 12 / PRODIGE 2随机试验的发现
机译:癌症临床试验疗效和毒性终点:比较两种非参数方法的仿真研究
机译:随机对照试验,以比较侧脊增速程序时软组织增强的组织形态和临床结果
机译:局部晚期直肠癌中三明治新辅助治疗的高pCR率可能转化为更好的长期生存获益:II期临床试验的5年结果
机译:OC-0480:直肠癌三期ACCORD 12新辅助试验的五年临床结果